News ‘Worrying’ rise in number of patients with a high anticholinergic burden Exclusive: Experts say the rise could be owing to the lack of contact between prescribers and patients during the COVID-19 pandemic.…Published: 19 October 2022
News Dementia diagnosis more likely in patients taking multiple medicines, study results suggest Researchers found that as a patient came closer to a dementia diagnosis, patterns of polypharmacy were linked with particular medical conditions.…Published: 19 October 2022
Feature Anticholinergic drugs and dementia: a causal link? The implications of changes to the regulation of oxybutynin in the UK and the case for deprescribing anticholinergics, such as this, to prevent cognitive adverse effects.…Published: 5 October 2022
Opinion Our multidisciplinary approach helped tackle polypharmacy in older patients A quality improvement project taught senior pharmacist Misba Janjua the benefits of working as part of a multidisciplinary team to review older patients with polypharmacy.…Published: 1 September 2022
News Some patients switched to edoxaban without being properly informed, pharmacists say Exclusive: Primary care pharmacists have revealed that patients are being switched to edoxaban without being informed or when it is not clinically appropriate.…Published: 31 August 2022
News Statins should not be stopped in older people owing to their benefits, say researchers People with lower cardiovascular disease risk who stopped taking statins aged 80 years lost 73% of their potential benefit if they took them for the rest of their lives, a modelling study has suggested.…Published: 25 August 2022
Opinion We must start using pharmacogenomic information to optimise medicines for older people Training in pharmacogenomic testing needs to be prioritised so that the NHS can benefit from the many advantages it has to offer, especially for older people at higher risk from adverse drug reactions.…Published: 13 July 2022
Feature Everything you need to know about the NHS genomic medicine service A closer look at the progress made so far on NHS England’s new national genomic medicine service.…Published: 21 June 2022
News Structured medication reviews should last at least 30 minutes, confirms NHS lead Speaking at the Primary Care Pharmacy Association conference, Tony Avery said it was important that structured medication reviews are maintained in terms of quality, including the time allocated.…Published: 9 June 2022
News NHS lead to investigate pharmacists being given just ten minutes for medication reviews Pharmacists say that quantity is being favoured over quality after primary care networks were offered financial incentives of around £16,400 to review high-risk patients.…Published: 19 May 2022
